Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. LEN
10. META

Go back to Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Regeneron (NASDAQ: REGN) Delayed: 789.45 --0 (-0%)
Previous Close $789.45    52 Week High $592.36 
Open $789.45    52 Week Low $325.35 
Day High $789.45    P/E 207.20 
Day Low $789.45    EPS $3.81 
Volume 208